|
|
|
Pharmaceutical Manufacturing and Packing Sourcer
|
|
As the world watched, the first approved COVID-19 vaccines were transported to the UK to start the mass immunisation process.
The global attention not only highlighted how the pharmaceutical manufacturing and supply chain sectors were working together to rapidly respond in the fight against the virus, it also focused on the cold chain challenges associated with the deployment and safe transportation of COVID-19 vaccines.
These challenges will continue to evolve as various vaccines, with varying temperature requirements for storage and shipment, are approved and transported worldwide.
Cold chain protection, throughout this distribution process, is essential. This can be packaging, or buildings and vehicles, but most crucial is a process to establish an unbroken cold chain. Colder temperatures are more difficult to maintain, as they may require more exotic coolants, such as dry ice, to achieve -80°C.
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
Adam Tetz is the Director of Worldwide Marketing at Peli BioThermal, and has more than 25 years of marketing experience. He is responsible for telling the story of Peli BioThermal to our worldwide audiences. His areas of responsibility include brand identity, product launch, and communication strategy. Prior to Peli BioThermal, Adam held positions in product management and marketing communication across a variety of industries, including medical software, financial software, information services, and professional consulting services. He holds an MBA in Marketing from the University of Saint Thomas, US, a BA in Advertising from the University of Minnesota, US, and is a veteran of the United States Coast Guard.
|
|
|
|
|
|
 |
News and Press Releases |
 |
Neopac’s Polyfoil MMB® Tube Approved by USA’s Association of Plastic Recyclers
Oberdiessbach, Switzerland – Hoffmann Neopac, a global provider
of high-quality packaging for pharma, beauty and oral care, has been
granted approval for its Polyfoil® MMB mono-material barrier tube by the
US-based Association of Plastic Recyclers. Offering a groundbreaking
combination of product protection, user friendliness and appealing
aesthetics, the tubes passed muster both with and without its thin film
metallization option.
More info >> |
|
 |
White Papers |
 |
|
Mauritius Island – An Emerging Centre for R&D in Biotechnology and the Life Sciences
CIDP (Centre International de Développement Pharmaceutique)
Mauritius, the tropical island situated in the Indian Ocean and known
worldwide for its beautiful beaches, is also internationally recognised
for its rule of law, and political and social stability. Over the past
few years, the economy has been successfully transitioned from a
monocrop to a diversified innovation-driven and knowledge-based economy,
resting on agribusiness, export-oriented manufacturing, tourism,
financial services, property development and real estate, ICT-BPO, the
seafood industry, a free port, logistics and a nascent ocean economy.
Emerging sectors such as healthcare and life sciences are presenting
some niche areas for the taking, and the enabling environment is being
put in place to make it happen - especially in the light of sustained
growth within pharmaceutical, medical device, and clinical research.
Important
international players are already in operation locally as the country
has established the appropriate legal and regulatory frameworks based on
international norms, for the development of a strong biomedical
research sector.
More info >> |
|
|
